{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:40:23Z","timestamp":1785760823940,"version":"3.56.0"},"reference-count":48,"publisher":"American Chemical Society (ACS)","issue":"18","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>DGK\u03b1, also named diacylglycerol kinase alpha, plays an important role in signal transduction, phosphorylating the membrane lipid diacylglycerol (DAG), to phosphatidic acid (PA). Increasing evidence indicates that DGK\u03b1-mediated T-cell dysfunction plays a significant role in the development of resistance of the PD-1 blockade. In this article, we report the discovery of compound 16 as a novel, potent, orally available DGK\u03b1 inhibitor with excellent kinase selectivity, a favorable ADME profile, and robust in vivo antitumor activity in combination with anti-PD-1 therapy.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.5c01944","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T05:34:11Z","timestamp":1757309651000},"page":"19645-19660","source":"Crossref","is-referenced-by-count":2,"title":["Discovery of\nNovel, Potent, Selective, and Orally\nAvailable DGK\u03b1 Inhibitors for the Treatment of Tumors"],"prefix":"10.1021","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8111-9362","authenticated-orcid":true,"given":"Hongfu","family":"Lu","sequence":"first","affiliation":[{"name":"Insilico Medicine Shanghai Ltd , Suite 901, Tower C, Changtai Plaza, 2889 Jinke Road, Pudong New District , ,","place":["Shanghai, China, 201203"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0082-6918","authenticated-orcid":true,"given":"Deheng","family":"Sun","sequence":"additional","affiliation":[{"name":"Insilico Medicine Shanghai Ltd , Suite 901, Tower C, Changtai Plaza, 2889 Jinke Road, Pudong New District , ,","place":["Shanghai, China, 201203"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Insilico Medicine Shanghai Ltd , Suite 901, Tower C, Changtai Plaza, 2889 Jinke Road, Pudong New District , ,","place":["Shanghai, China, 201203"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujing","family":"Shi","sequence":"additional","affiliation":[{"name":"Insilico Medicine Shanghai Ltd , Suite 901, Tower C, Changtai Plaza, 2889 Jinke Road, Pudong New District , ,","place":["Shanghai, China, 201203"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3438-3495","authenticated-orcid":true,"given":"Huaxing","family":"Yu","sequence":"additional","affiliation":[{"name":"Insilico Medicine Shanghai Ltd , Suite 901, Tower C, Changtai Plaza, 2889 Jinke Road, Pudong New District , ,","place":["Shanghai, China, 201203"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Cui","sequence":"additional","affiliation":[{"name":"Insilico Medicine Shanghai Ltd , Suite 901, Tower C, Changtai Plaza, 2889 Jinke Road, Pudong New District , ,","place":["Shanghai, China, 201203"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Cai","sequence":"additional","affiliation":[{"name":"Insilico Medicine Shanghai Ltd , Suite 901, Tower C, Changtai Plaza, 2889 Jinke Road, Pudong New District , ,","place":["Shanghai, China, 201203"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3482-1870","authenticated-orcid":true,"given":"Xiao","family":"Ding","sequence":"additional","affiliation":[{"name":"Insilico Medicine Shanghai Ltd , Suite 901, Tower C, Changtai Plaza, 2889 Jinke Road, Pudong New District , ,","place":["Shanghai, China, 201203"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Chen","sequence":"additional","affiliation":[{"name":"Insilico Medicine Shanghai Ltd , Suite 901, Tower C, Changtai Plaza, 2889 Jinke Road, Pudong New District , ,","place":["Shanghai, China, 201203"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Zhang","sequence":"additional","affiliation":[{"name":"Insilico Medicine Shanghai Ltd , Suite 901, Tower C, Changtai Plaza, 2889 Jinke Road, Pudong New District , ,","place":["Shanghai, China, 201203"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4363-0710","authenticated-orcid":true,"given":"Alex","family":"Aliper","sequence":"additional","affiliation":[{"name":"Insilico Medicine AI Ltd , , ,","place":["Masdar City, Abu Dhabi, United Arab Emirates, 145748"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9157-9182","authenticated-orcid":true,"given":"Feng","family":"Ren","sequence":"additional","affiliation":[{"name":"Insilico Medicine Shanghai Ltd , Suite 901, Tower C, Changtai Plaza, 2889 Jinke Road, Pudong New District , ,","place":["Shanghai, China, 201203"]},{"name":"Insilico Medicine Hong Kong Ltd, Hong Kong Science and Technology Park , ,","place":["Hong Kong, China, 999077"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7067-8966","authenticated-orcid":true,"given":"Alex","family":"Zhavoronkov","sequence":"additional","affiliation":[{"name":"Insilico Medicine Shanghai Ltd , Suite 901, Tower C, Changtai Plaza, 2889 Jinke Road, Pudong New District , ,","place":["Shanghai, China, 201203"]},{"name":"Insilico Medicine AI Ltd , , ,","place":["Masdar City, Abu Dhabi, United Arab Emirates, 145748"]},{"name":"Insilico Medicine Hong Kong Ltd, Hong Kong Science and Technology Park , ,","place":["Hong Kong, China, 999077"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"issue":"729","key":"2026073102161466700_cit1","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.abo0264","article-title":"Overarching Roles of Diacylglycerol Signaling in Cancer\nDevelopment and Antitumor Immunity","volume":"15","author":"Cooke","year":"2022","journal-title":"Sci. Signal"},{"issue":"13","key":"2026073102161466700_cit2","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1042\/CS20200389","article-title":"Potential\nRole of Diacylglycerol\nKinases in Immune-Mediated Diseases","volume":"134","author":"Baldanzi","year":"2020","journal-title":"Clin. Sci."},{"issue":"10","key":"2026073102161466700_cit3","doi-asserted-by":"publisher","first-page":"6186","DOI":"10.1021\/cr1004106","article-title":"Regulation\nand Functions of Diacylglycerol\nKinases","volume":"111","author":"Shulga","year":"2011","journal-title":"Chem. Rev."},{"issue":"20","key":"2026073102161466700_cit4","doi-asserted-by":"publisher","first-page":"5190","DOI":"10.3390\/cancers13205190","article-title":"The Roles\nof Diacylglycerol Kinase \u03b1 in Cancer Cell Proliferation and\nApoptosis","volume":"13","author":"Sakane","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"7","key":"2026073102161466700_cit5","doi-asserted-by":"publisher","first-page":"5254","DOI":"10.1074\/jbc.M110.171884","article-title":"Decreased Diacylglycerol Metabolism\nEnhances ERK Activation and Augments CD8+ T Cell Functional Responses","volume":"286","author":"Riese","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"11","key":"2026073102161466700_cit6","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1038\/ni1394","article-title":"T Cell Anergy Is Reversed by Active Ras and Is Regulated\nby Diacylglycerol Kinase-\u03b1","volume":"7","author":"Zha","year":"2006","journal-title":"Nat. Immunol."},{"issue":"11","key":"2026073102161466700_cit7","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/ni1400","article-title":"Disruption\nof Diacylglycerol Metabolism Impairs the\nInduction of T Cell Anergy","volume":"7","author":"Olenchock","year":"2006","journal-title":"Nat. Immunol."},{"issue":"12","key":"2026073102161466700_cit8","doi-asserted-by":"publisher","first-page":"5990","DOI":"10.4049\/jimmunol.1103028","article-title":"High DGK-\u03b1 and\nDisabled MAPK Pathways Cause Dysfunction\nof Human Tumor-Infiltrating CD8+ T Cells That Is Reversible by Pharmacologic\nIntervention","volume":"188","author":"Prinz","year":"2012","journal-title":"J. Immunol."},{"issue":"11","key":"2026073102161466700_cit9","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1007\/s00262-021-02924-5","article-title":"Diacylglycerol Kinase \u03b1 Inhibition\nCooperates with PD-1-Targeted Therapies to Restore the T Cell Activation\nProgram","volume":"70","author":"Arranz-Nicola\u0301s","year":"2021","journal-title":"Cancer Immunol Immunother"},{"issue":"719","key":"2026073102161466700_cit10","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adh1892","article-title":"DGK\u03b1\/\u03b6 Inhibitors Combine\nwith PD-1 Checkpoint Therapy\nto Promote T Cell\u2013Mediated Antitumor Immunity","volume":"15","author":"Wichroski","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"2026073102161466700_cit11","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3389\/fcell.2016.00108","article-title":"Diacylglycerol\nKinases\n(DGKs): Novel Targets for Improving T Cell Activity in Cancer","volume":"4","author":"Riese","year":"2016","journal-title":"Front. Cell Dev. Biol."},{"key":"2026073102161466700_cit12","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3389\/fcell.2016.00130","article-title":"Diacylglycerol\nKinases in T Cell Tolerance and Effector\nFunction","volume":"4","author":"Chen","year":"2016","journal-title":"Front. Cell Dev. Biol."},{"issue":"6","key":"2026073102161466700_cit13","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/icb.2017.7","article-title":"Predominant Contribution of DGK\u03b6\nover DGK\u03b1\nin the Control of PKC\/PDK-1-regulated Functions in T Cells","volume":"95","author":"A\u0301vila-Flores","year":"2017","journal-title":"Immunol Cell Biol."},{"key":"2026073102161466700_cit14","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2017.00016","article-title":"DGK-\u03b1: A\nCheckpoint in Cancer-Mediated Immuno-Inhibition and Target for Immunotherapy","volume":"5","author":"Noessner","year":"2017","journal-title":"Front. Cell Dev. Biol."},{"key":"2026073102161466700_cit15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00178","article-title":"Regulation of Lipid Signaling\nby Diacylglycerol Kinases during T Cell Development and Function","volume":"4","author":"Krishna","year":"2013","journal-title":"Front Immunol"},{"issue":"3","key":"2026073102161466700_cit16","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1021\/acs.jcim.2c01191","article-title":"Chemistry42: An AI-Driven Platform for Molecular Design\nand Optimization","volume":"63","author":"Ivanenkov","year":"2023","journal-title":"J. Chem. Inf. Model."},{"issue":"11","key":"2026073102161466700_cit17","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1021\/acs.jcim.3c00562","article-title":"Exploring\nthe Advantages\nof Quantum Generative Adversarial Networks in Generative Chemistry","volume":"63","author":"Kao","year":"2023","journal-title":"J. Chem. Inf. Model."},{"issue":"22","key":"2026073102161466700_cit18","doi-asserted-by":"publisher","first-page":"20580","DOI":"10.1021\/acs.jmedchem.4c02098","article-title":"Discovery\nof a Novel Macrocyclic Noncovalent CDK7 Inhibitor for Cancer Therapy","volume":"67","author":"Lu","year":"2024","journal-title":"J. Med. Chem."},{"issue":"21","key":"2026073102161466700_cit19","doi-asserted-by":"publisher","first-page":"19121","DOI":"10.1021\/acs.jmedchem.4c01580","article-title":"Discovery of Bis-Imidazolecarboxamide Derivatives as Novel, Potent,\nand Selective TNIK Inhibitors for the Treatment of Idiopathic Pulmonary\nFibrosis","volume":"67","author":"Aladinskiy","year":"2024","journal-title":"J. Med. Chem."},{"issue":"10","key":"2026073102161466700_cit20","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.1021\/acs.jcim.3c01619","article-title":"PandaOmics:\nAn AI-Driven Platform for Therapeutic Target\nand Biomarker Discovery","volume":"64","author":"Kamya","year":"2024","journal-title":"J. Chem. Inf. Model."},{"key":"2026073102161466700_cit21","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1038\/s41591-025-03743-2","article-title":"A Generative\nAI-Discovered TNIK Inhibitor for Idiopathic Pulmonary Fibrosis: A\nRandomized Phase 2a Trial","volume":"31","author":"Xu","year":"2025","journal-title":"Nat. Med."},{"issue":"22","key":"2026073102161466700_cit22","doi-asserted-by":"publisher","first-page":"8380","DOI":"10.1039\/D4SC00966E","article-title":"Nach0: Multimodal Natural and Chemical Languages Foundation\nModel","volume":"15","author":"Livne","year":"2024","journal-title":"Chem. Sci."},{"issue":"8","key":"2026073102161466700_cit23","doi-asserted-by":"publisher","first-page":"8065","DOI":"10.1021\/acs.jmedchem.4c02541","article-title":"Discovery of WEE1 Kinase Inhibitors\nwith Potent Activity against Patient-Derived, Metastatic Colorectal\nCancer Organoids","volume":"68","author":"Syphers","year":"2025","journal-title":"J. Med. Chem."},{"issue":"7","key":"2026073102161466700_cit24","doi-asserted-by":"publisher","first-page":"7518","DOI":"10.1021\/acs.jmedchem.4c03225","article-title":"Discovery of Novel SIK2\/3 Inhibitors\nfor the Potential Treatment\nof MEF2C+ Acute Myeloid Leukemia (AML)","volume":"68","author":"Zhu","year":"2025","journal-title":"J. Med.\nChem."},{"issue":"4","key":"2026073102161466700_cit25","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.1021\/acs.jmedchem.4c01616","article-title":"Design, Synthesis,\nand Biological Evaluation of Novel Orally Available Covalent CDK12\/13\nDual Inhibitors for the Treatment of Tumors","volume":"68","author":"Lu","year":"2025","journal-title":"J. Med. Chem."},{"issue":"3","key":"2026073102161466700_cit26","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1021\/acs.jmedchem.4c03205","article-title":"Discovery of Pyrrolopyrazine\nCarboxamide Derivatives as Potent and Selective FGFR2\/3 Inhibitors\nThat Overcome Mutant Resistance","volume":"68","author":"Wang","year":"2025","journal-title":"J. Med. Chem."},{"issue":"2","key":"2026073102161466700_cit27","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1021\/acs.jmedchem.4c02732","article-title":"Discovery\nof Potent, Highly Selective, and Orally Bioavailable\nMTA Cooperative PRMT5 Inhibitors with Robust In Vivo Antitumor Activity","volume":"68","author":"Zhang","year":"2025","journal-title":"J. Med. Chem."},{"issue":"23","key":"2026073102161466700_cit28","doi-asserted-by":"publisher","first-page":"21520","DOI":"10.1021\/acs.jmedchem.4c02421","article-title":"Discovery of Pyridine-2-Carboxamides\nDerivatives as\nPotent and Selective HPK1 Inhibitors for the Treatment of Cancer","volume":"67","author":"Peng","year":"2024","journal-title":"J. Med. Chem."},{"issue":"8","key":"2026073102161466700_cit29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1089\/gen.44.08.13","article-title":"Is Generative\nAI in Drug Discovery Overhyped?","volume":"44","author":"Zhavoronkov","year":"2024","journal-title":"Genet. Eng.\nBiotechnol. News"},{"key":"2026073102161466700_cit30","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-024-02503-w","article-title":"Intestinal Mucosal Barrier Repair\nand Immune Regulation with an AI-Developed Gut-Restricted PHD Inhibitor","author":"Fu","year":"2024","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"2026073102161466700_cit31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41587-024-02143-0","article-title":"A Small-Molecule TNIK Inhibitor Targets\nFibrosis in Preclinical and Clinical Models","volume":"43","author":"Ren","year":"2025","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"2026073102161466700_cit32","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.18632\/aging.203960","article-title":"Hallmarks\nof Aging-Based Dual-Purpose Disease and Age-Associated\nTargets Predicted Using PandaOmics AI-Powered Discovery Engine","volume":"14","author":"Pun","year":"2022","journal-title":"Aging"},{"issue":"29","key":"2026073102161466700_cit33","doi-asserted-by":"publisher","first-page":"15762","DOI":"10.1016\/S0021-9258(17)36324-X","article-title":"R 59\n022, a diacylglycerol kinase inhibitor. Its effect on diacylglycerol\nand thrombin-induced C kinase activation in the intact platelet","volume":"260","author":"de Chaffoy de Courcelles","year":"1985","journal-title":"J. Biol. Chem."},{"issue":"6","key":"2026073102161466700_cit34","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.1016\/S0021-9258(18)94063-9","article-title":"The Role of\nEndogenously Formed Diacylglycerol in the Propagation and Termination\nof Platelet Activation","volume":"264","author":"de Chaffoy de Courcelles","year":"1989","journal-title":"J. Biol. Chem."},{"issue":"1\u20132","key":"2026073102161466700_cit35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000351849","article-title":"Evaluations of the Selectivities\nof the Diacylglycerol Kinase Inhibitors R59022 and R59949 Among Diacylglycerol\nKinase Isozymes Using a New Non-Radioactive Assay Method","volume":"92","author":"Sato","year":"2013","journal-title":"Pharmacology"},{"key":"2026073102161466700_cit36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bcp.2016.10.011","article-title":"Dual Activities\nof Ritanserin and R59022 as DGK\u03b1 Inhibitors and Serotonin Receptor\nAntagonists","volume":"123","author":"Boroda","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"2026073102161466700_cit37","doi-asserted-by":"publisher","first-page":"A840","DOI":"10.1136\/jitc-2024-SITC2024.0737","article-title":"737 Optimal Enhancement of Anti-Tumor\nT-Cell Immunity through the Combined Use of Selective DGK Zeta and\nDGK Alpha Inhibitors","volume-title":"Regular and Young\nInvestigator Award Abstracts","author":"Offringa","year":"2024"},{"key":"2026073102161466700_cit38","unstructured":"Gentles, R. G.; Velaparthi, U.; Ding, M.; Olson, R. E.; Martin, S. W.; Roy, S.; Jalagam, P. R.; Warrier, J. S.; Chupak, L. S.; Grunenfelder, D. C.\n          Preparation\nof Substituted Bicyclic\nCompounds Useful as T Cell Activators for Treatment of Viral Infections\nand Proliferative Disorders, June 24, 2021."},{"key":"2026073102161466700_cit39","unstructured":"Sawa, M.; Arai, M.; Nakai, R.; Matsumoto, H.; Pugh, C.; Hu, E.; Guerrero, J.; Jacobsen, J.; Medley, J. W.; Xu, J.; Lad, L.; Patel, L.; Graupe, M.; Zhu, Q.; Holmbo, S.; Kobayashi, T.; Watkins, W.; Moazami, Y.; Yeung, S. C.; Codelli, J. A.; Weaver, H. A.\n          Triazoloquinazolines\nas Diacylglycerol\nKinase Modulating Compounds and Their.  Preparation July 1, 2021."},{"issue":"6264","key":"2026073102161466700_cit40","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/344345a0","article-title":"Porcine Diacylglycerol\nKinase Sequence Has Zinc Finger and E\u2013F Hand Motifs","volume":"344","author":"Sakane","year":"1990","journal-title":"Nature"},{"issue":"4","key":"2026073102161466700_cit41","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/pro.3572","article-title":"Crystal Structure and Calcium-induced Conformational\nChanges of Diacylglycerol Kinase \u03b1 EF-hand Domains","volume":"28","author":"Takahashi","year":"2019","journal-title":"Protein Sci."},{"issue":"6","key":"2026073102161466700_cit42","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1039\/D2SC05709C","article-title":"AlphaFold Accelerates Artificial\nIntelligence Powered Drug Discovery: Efficient Discovery of a Novel\nCDK20 Small Molecule Inhibitor","volume":"14","author":"Ren","year":"2023","journal-title":"Chem. Sci."},{"key":"2026073102161466700_cit43","unstructured":"Velaparthi, U.; Chupak, L. S.; Darne, C. P.; Ding, M.; Gentles, R. G.; Huang, Y.; Kamble, M. N. R.; Martin, S. W.; Mannoori, R.; McDonald, I. M.; Olson, R. E.; Rahaman, H.; Jalagam, P. R.; Roy, S.; Tonukunuru, G.; Velaiah, S.; Warrier, J. S.; Zheng, X.; Tokarski, J. S.; Dasgupta, B.; Reddy, K. R.; Raja, T.\n          Preparation of\nSubstituted Naphthyridinone Compounds Useful as T Cell Activators, WO2020006018A1, 2020."},{"issue":"7873","key":"2026073102161466700_cit44","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41586-021-03828-1","article-title":"Highly Accurate Protein Structure Prediction for the\nHuman Proteome","volume":"596","author":"Tunyasuvunakool","year":"2021","journal-title":"Nature"},{"issue":"D1","key":"2026073102161466700_cit45","doi-asserted-by":"publisher","first-page":"D368","DOI":"10.1093\/nar\/gkad1011","article-title":"AlphaFold Protein Structure Database\nin 2024: Providing Structure Coverage for over 214 Million Protein\nSequences","volume":"52","author":"Varadi","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"2026073102161466700_cit46","volume-title":"Drug-like Properties:\nConcepts, Structure Design and Methods from ADME to Toxicity Optimization","author":"Di","year":"2015"},{"key":"2026073102161466700_cit47","volume-title":"Exploring\nQSAR.: Fundamentals and\nApplications in Chemistry and Biology. Hydrophobic, Electronic, and\nSteric Constants","author":"Hansch","year":"1995"},{"issue":"2","key":"2026073102161466700_cit48","first-page":"146","article-title":"About the\nEvaluation of Drug Combination","volume":"25","author":"Jin","year":"2004","journal-title":"Acta Pharmacol.\nSin."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.5c01944","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/68\/18\/19645\/66295922\/acs.jmedchem.5c01944.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/68\/18\/19645\/66295922\/acs.jmedchem.5c01944.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T06:16:18Z","timestamp":1785478578000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/68\/18\/19645\/5234843\/Discovery-of-Novel-Potent-Selective-and-Orally"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":48,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2025,9,8]]},"published-print":{"date-parts":[[2025,9,25]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c01944","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,8]]}}}